Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
August 2025
The global toxicology testing services market size is accounted at USD 41.24 billion in 2025 and is forecasted to hit around USD 67.34 billion by 2034, representing a CAGR of 5.60% from 2025 to 2034.
The global toxicology testing services market size was calculated at USD 39.05 billion in 2024 and is predicted to reach around USD 67.34 billion by 2034, expanding at a CAGR of 5.60% from 2025 to 2034. The increasing demand for the early-stage diagnostics testing method in the drug development process more sustainably is driving the growth of the toxicology testing services market.
Integrating artificial intelligence and machine learning in testing significantly transforms the toxicology testing services market. AI rapidly analyzes the vast amount of data more efficiently. AI and machine learning used different approaches in different types of toxicology, such as quantitative structure-activity relationship modeling for toxicity prediction, physiologically based pharmacokinetic (PBPK) modeling, big data, toxicogenomics, high-throughput screening, adverse outcome pathway analysis, and toxicological databases. By integrating AI into PBPK modeling, there is the possibility of developing a number of chemicals.
Toxicology is one of the important parts of biomedical research. It is the process that assesses the potential health risks and safety of substances, chemicals, and products. Toxicology identifies and analyzes the substance on living organisms, identifying the potential risk to human health, environment, and animal welfare. It is simply used by a number of industries, such as pharmaceuticals, cosmetics, food, and others, to detect hazardous chemicals or substances from products that affect human health. Acute toxicity testing, chronic toxicity testing, in vitro toxicology testing, in vivo toxicology testing, and ecotoxicology testing are some types of toxicology testing.
| Report Coverage | Details |
| Market Size by 2024 | USD 39.05 Billion |
| Market Size in 2025 | USD 41.24 Billion |
| Market Size in 2034 | USD 67.34 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 5.60% |
| Leading Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Method, Industry, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Increasing awareness regarding toxicology services
The rising awareness regarding the several benefits of toxicology in different industries and products is driving the growth of the toxicology testing services market. Toxicology testing services ensure product safety by providing clinical data of the product, compliance with the regulatory framework that helps in providing product approval, and avoiding any legal issues. Toxicology testing services help to reduce potential misconceptions. It also enables safer product development with more innovations. It provides valuable insights to industries that need to make informed decisions regarding the product.
High-cost method
The increased cost associated with toxicology testing, time-consuming process, inconsistent response, low-throughput readouts, extrapolability to humans, and ethical issues related to the services are limiting the growth of the toxicology testing services market.
Advancements in technology
In the toxicology testing services market, the continuous investment in research and development programs for the further technological development of clinical testing technologies such as kinetic issue culture method, 3D human tissue constructs, and co-culture systems as replacements to animal testing. Additionally, there is a rising demand for sustainable and eco-friendly approaches to biomedical research.
The in-vitro testing segment held the largest share of 62.50% in the 2024 toxicology testing services market. The in-vitro testing involves cellular, biochemical, and molecular toxicology assays. The cellular assays include live cells, molecular imaging, fixed cells, high throughput (high content screening), and confocal microscopy. The cellular assays are crucial in global toxicology testing, providing a speedy, cost-effective option to animal testing, especially for safe assessment and drug discovery. In vitro testing enables laboratory-related methods to check safety measurements in drugs and chemicals with the help of tissues and cultured cells, avoiding experimentation on live animals. This kind of approach accelerates the growth of the in-vitro testing method.
The in-vivo testing segment is expected to grow at a CAGR of 9.10% during the forecast period. The in-vivo testing is a complex method in the global toxicology testing services, including experimentation on live animals to address the complexity and physiological side effects of the drug or substance. This method is a long-established method in drug development and safety. The segment is steadily growing with the specific demand and need for in-vivo testing for extreme drugs, which need accuracy and unambiguous validation, to further commercialize on a global platform.
The pharmaceutical and biotechnology segment dominated the toxicology testing services market in 2024. The growth of the market is attributed to the rising healthcare and pharmaceutical industry owing to the rising population, rise in geriatric population, and widespread of various diseases are causing the demand for the treatment medication or drugs which contributing to the widespread adoption of toxicology testing services for identifying the toxicity of the drug and effects on the live sample. The rising government interventions in the development of the pharmaceutical infrastructure with continuous investment.
The medical devices segment will witness substantial growth in the toxicology testing services market during the predicted period. The evaluation of the toxicology testing of medical devices is one of the most important parts of healthcare for patient safety. The toxicology testing helps in assessing the toxicological and biological of the medical device. Medical devices are one of the important parts of patient diagnostics. The rising investment in the development and continuous research in the evaluation of medical devices or products boosts the demand for toxicology testing services in the medical devices industry.
North America dominated the global toxicology testing services market in 2024. The growth of the market is attributed to the rising healthcare and pharmaceutical infrastructure, and the growing prevalence of different diseases in the population is accelerating the demand for drug development, which causes the increased demand for toxicology testing services. The rising adaptation of technologies in industrial operations and the availability of leading healthcare technologies and pharmaceutical firms.
Europe expects significant growth in the toxicology testing services market during the forecast period. The rising spread of disease, growing geriatric population, and demand for effective medication and treatment procedures are driving the growth of the pharmaceutical industry, which is anticipated to expand the demand for toxicology testing services. The different regulations on chemical assessment and drug development, while the government maintains safety standards.
Asia Pacific is experiencing substantial growth in the toxicology testing services market. The market's growth is attributed to the rising healthcare infrastructure and overall spending on healthcare by the population, and the government intervention in the development of the pharmaceutical and healthcare sector is driving the number of medication or drug launches.
The ADME toxicology testing segment held the largest share of 18.60% in the 2024 toxicology testing services market. The ADME stands for absorption, distribution, metabolism, and excretion. The segment is in demand with the increased renal, hepatic, developmental, acute, chronic, reproductive, and systemic toxicity. The ADME testing is an examination of the body’s processing ability and reaction to the drug or certain chemical to address the efficacy and safety of the drug. The technological advancement, such as in silico and in vitro methods, is a developmental progress in the market to meet emerging regulatory demands.
The immunotoxicity and endocrine disruption (driven by biologics and regulatory focus) segment is expected to grow at a CAGR of 9.70% during the forecast period. The endocrine and immunotoxicity disruption is one of the complex toxicology concerns, as chemicals or drugs can disturb the endocrine system and the body’s immune system, which leads to several health conditions. With the global toxicology testing services providing in-vivo and in-vitro methods, with the regulatory-fueled idea, and mechanical study has fixed the biologics focus on a solution to these disruptions.
The cell culture technology segment held the largest share of 24.90% in the 2024 toxicology testing services market. The cell culture technology stands in a crucial position in the global in vitro toxicology testing due to its ability to serve cost-effective, humanly models and a reliable source for substance and drug safety purposes. The advancements, such as organ-on-a-chip platform, AI/ML integration, high-throughput screening, and 3D cell cultures, are improving the well-analyzed efficiency and accuracy. The cell culture is transitioning the toxicology pipeline, enabling accurate, systematic, and fastest examination of active toxicants.
The toxicogenomics (omics technology) is expected to grow at a CAGR of 10.20% during the forecast period. The omics technology evaluates other biological molecules and genes' response to the toxic substance and provides an accurate, substantially animal-free, and fastest option to the traditional toxicology testing. The major development in omics technology involves integrating machine learning with high-throughput technologies to advance global toxicology testing services.
The agrochemical industry is expected to grow at a CAGR of 8.80% during the forecast period. The industry highly epends on toxicology testing to cross-check with fertilizers, pesticides, and the purity level. To examine products safety for both the environment and humans is essential to survive and balance these two aspects. The increasing development of the new crop safety solutions and ensuring strong regulatory compliance will stimulate the growth of the agrochemical company. Following this, the role of operator/bystander exposure studies and ecotoxicity studies is essential in the global toxicology testing services.
By Method
By Toxicity Endpoint & Test
By Technology
By End-User Industry
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
August 2025
April 2025
February 2025
December 2024